Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page
- Check6 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0 in the metadata. This is a minor versioning update and does not alter study content or functionality.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page now shows a glossary and QC-related metadata (Last Update Submitted that Met QC Criteria) along with No FEAR Act Data and Revision: v3.4.0. The older QC field capitalization (Last Update Submitted that met QC Criteria), the No FEAR Act data, and Revision: v3.3.4 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.3.4 replaced the prior v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded a detailed Locations section listing participating sites across the United States, Canada, United Kingdom, Australia, and Japan. This helps potential participants identify nearby sites and understand where the study is being conducted.SummaryDifference2%

- Check72 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and that the page now displays Revision: v3.3.1. Removed the older PubMed-origin wording and Revision: v3.2.0 reference.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.